ABSTRACT
and VEGF 165 are secreted forms whereas VEGF 183, VEGF 189 and VEGF 206 are the forms bound to the cell membrane (2) . VEGF 165 is the most abundant and biologically active isoform. This isoform is secreted by cells but a significant fraction remains bound to the cell membrane via the extracellular matrix (1, 2) .
Recent studies on circulating levels of VEGF demonstrate the prognostic importance of serum VEGF concentration in a variety of diseases including atherosclerosis, ischemic heart disease, diabetic retinopathy, inflammatory diseases, and many types of tumors, pathologic conditions often leading to hypoxia (3, 4) . Other papers have proposed the circulating VEGF as a possible biomarker for diagnosis, monitoring of disease activity, treatment response and erosive progression in patients with chronic diseases, such as rheumatoid arthritis (5) (6) (7) (8) (9) . It has been shown that VEGF is constitutively produced by megacaryocytes and platelets (10) . It is released from platelets after blood clotting (11) , and VEGF levels are higher in serum than in plasma; the pre-centrifugation delay induces an increase of VEGF in Ethylene diamine tetraacetic acid (EDTA) plasma samples. The delay before freezing and the number of freezethaw cycles influence VEGF measures in urine (12) . Recently, it was shown that serum VEGF is decreased after long term storage and freeze thawing (13) . Some studies have shown the need for assay validation of sample handling before the start of biomarker analysis in clinical trials while their report indicates that removal of platelets reduced the plasma concentration of VEGF, if the platelets were removed before freezing plasma samples (14) .
The extended role of VEGF in human pathophysiology underpins the importance of improving knowledge on the pre-analytical and analytical variation factors and thus the accuracy of laboratory analysis of VEGF. We previously reported inter-individual biological variations and defined reference values of VEGF levels in EDTA plasma (5) . However, little is known on pre-analytical variations of VEGF isoforms and corresponding gene expression .The aims of the present study are to evaluate the effects of pre-analytical factor on VEGF expression in blood and non-tumor tissues. More precisely, we evaluated the influence of the presence and the nature of anticoagulants, of the blood storage delay before centrifugation and of the number of freeze-thaw cycles on circulating levels of VEGF and on VEGF 165 mRNA expression in peripheral blood mononuclear cells (PBMCs). We also evaluated the influence of nontumor tissue freezing delay on VEGF protein expression.
Materials and Methods

Biospecimens collection and pre-analytical conditioning
Blood specimens from 27 healthy donors from the "Investigation Clinique et Accès aux
Ressources Biologiques" (ICAReB) Platform at Institut Pasteur and from 9 healthy donors from Picardie Biobank were collected. All donors signed an informed consent ; the study was approved by the ethics committee CPP Ile-de-France I and the resulting sample collection de- kit, Roche Diagnostic, France), melting curves analysis and agarose gel electrophoresis of the PCR amplicons, as previously described (15) . Stability of the normalization gene β-2 microglobulin was assessed according to its related protocol (16) , for the delay times of 2, 4 and 48 hours before centrifugation.
VEGF expression in muscle biopsies
Thawed muscle biopsy sections from each time point were stained together. (17).
Statistical analyses
Descriptive statistics for VEGF levels are presented as the median and 25 th and 75 th percentiles.
VEGF levels, measured from different anticoagulant types and after different freeze-thaw cycle numbers, were compared using Wilcoxon's rank sum test. We considered p≤ 0.05 significant for differences between variables. Results are expressed as the ratio (percentage) between a given value at a specific pre-centrifugation delay and the corresponding value obtained at the 2-hour delay, or as the ratio between a value obtained at a specific number of freeze-thaw cycles and the corresponding value obtained with only one thawing. For mRNA analysis, only the pre-centrifugation delay was studied, with just one thawing of the PBMCs in all cases.
For muscle biopsies analysis, means comparison using ANOVA test were calculated with JMP 8.0 software.
Results
We initially performed comparison of the values of VEGF concentrations at the baseline (2 hours pre-centrifugation delay and 1 freeze-thaw cycle) between the collection centers and no difference was observed for any of the collection tubes used. The analysis reports the aggregated results of all donors at particular time points.
Effect of blood storage at 4°C before centrifugation on serum/plasma VEGF
VEGF recovery percentages in serum and plasma sampled with different anticoagulant types and after different pre-centrifugation delays at 3-8°C are presented in Figure 1 and in Table 1 .
When serum samples were only thawed once before analysis, there was no significant difference between 2 and 4 hours, neither was there between 2 and 48 hours of blood storage at 3-8°C. There was a significant increase (124%; p = 0.0009) between 2 and 48 hours of serum pre-centrifugation delay when the samples were analyzed after 2 freeze-thaw cycles.
In EDTA plasma samples, no significant difference was observed between 2 and 4 hour-precentrifugation delay, whatever the number of freeze-thaw cycles. In contrast, there was a significant increase between 2 and 48 hours, for all numbers of freeze-thaw cycles.
Similarly, the effect of blood storage time, when using hirudin as the anticoagulant, was not significant between 2 and 4 hours, however when the delay reached 48 hours, a highly significant VEGF increase was observed, for all numbers of freeze-thaw cycles.
The impact of ACD on VEGF analysis was different. Although a significant increase was observed between 2 and 4 hours (p=0.0046) and between 2 and 48 hours (p=0.006) with only one freeze-thaw cycle, this increase was no longer detectable after multiple freeze-thaw cycles.
3.2.Effect of the number of serum/plasma freeze-thaw cycles on measured VEGF
VEGF recovery percentages in serum and plasma obtained in different anticoagulant types and after different numbers of freeze-thaw cycles are shown in Figure 2 and Table 2 .
The VEGF level in serum is not affected by the number of freeze-thaw cycles whatever the delay of blood storage at 3-8°C after sampling.
VEGF levels in EDTA plasma significantly increased with the number of freeze-thaw cycles and this increase was similarly observed for the three blood storage delays. The VEGF increase was greater after 10 (p<0.0001) than after 2 (p=0.0046) freeze-thaw cycles.
VEGF levels in hirudin plasma remained the same after 1 and 2 freeze-thaw cycles and showed a slight increase after 10 cycles (p=0.005 and 0.008 for storage delays of 2 h and 48 h respectively).
The most important effect of freeze-thawing was observed in ACD plasma. Between 1 and 2
cycles, a very significant increase was observed (p<0.0001 at 2 h and 4 h time points). Interestingly, this increase was less significant when considering the 48 h delay (p=0.0047 and 0.0029 when comparing 1 to 2 cycles, and 1 to 10 cycles, respectively).
Effect of blood storage at 3-8°C on VEGF expression
There was no significant variation in the VEGF/β-2 microglobulin expression ratio in PBMCs isolated and stored 2 vs 4 hours at 3-8°C after blood sampling ( Figure 3 ). In contrast, a very significant increase was observed after 48 hours of blood storage, as compared to 2 h, with the three anticoagulants (EDTA and hirudin: p=0.0003; ACD: p<0.0001)
Effect of the blood collection tube type on circulating VEGF levels
Plasma circulating VEGF levels were significantly different depending on the collection tube type used . The measured levels were significantly higher in serum than in any type of plasma (p<0.0001). Among the three different types of plasma, VEGF levels were significantly higher in EDTA than in hirudin ( p<0.0001), or in ACD ( p=0.0002) (table 3).
Effect of freezing delay on VEGF protein expression levels in muscle tissues
Mean standardized fluorescence from VEGF-A stained muscle biopsy sections frozen after the 3 different delays showed a trend to increase with time from 15 to 60 min but with a peak of 
Discussion
VEGF has been proposed as a possible prognostic biomarker in several cancers (18) (19) (20) (21) (22) , a predictive biomarker for response to treatment in chronic inflammatory diseases (6, 23) , and as a physiological marker of vascular remodeling and growth regulation (24) (25) (26) . Reference values for healthy and diseased individuals must be determined to allow correct interpretation of patient's laboratory reports. Moreover, these values need to be reproducible from one laboratory to another, which means that pre-analytical and analytical parameters should be well defined.
In the present study, we have shown that VEGF measurements in serum and in plasma containing different anticoagulants are not comparable. The concentration of VEGF in serum was higher than in the different types of plasma and it was not significantly affected by the number of freeze-thaw cycles, neither was it by the storage delay at 3-8°C before centrifugation. When serum is collected for clinical immunological analyses, blood usually coagulates at room temperature for at least 30 minutes (27) . However, for the purposes of this study, all precentrifugations delays were performed at 4°C and the coagulation after 2H at 4°C was completed.
Using anticoagulants, VEGF values increased after 2 freeze-thaw cycles. There was an even higher increase after 10 freeze-thaw cycles in EDTA and hirudin plasma. However, although significant increases represented only 20% in EDTA and hirudin plasma, whereas more than 2 times higher VEGF was recovered in ACD plasma, after only 2 freeze-thaw cycles. This could be due to a better preservation of platelets in ACD, and thus, to a greater cumulated release of VEGF from platelets as they got lysed at each freeze-thaw event. Better preservation of platelets in ACD may also explain the fact that pre-centrifugation delays induced a lower VEGF increase in ACD than in EDTA or hirudin plasma. When ACD plasma is collected for analysis of coagulation factors, blood is usually centrifuged at a higher g-force and a second centrifugation reduces the number of platelets (28) . However, for the purposes of this study, platelet-rich plasma was used with all types of anticoagulants tested, including ACD. VEGF was much higher in serum than in any anticoagulant-collected plasma and this was probably due to a massive VEGF release from platelets during the coagulation process in the first 30 minutes after blood collection. This is in accordance with the work conducted by Banks et al (11) who have shown that VEGF increased in a first step during clotting, and the maximal increase was obtained after complete coagulation of the samples. Therefore, VEGF measured in serum does not correspond only to circulating but also to intracellular VEGF.
We showed that the blood storage period before centrifugation has a significant influence on VEGF levels in three types of anticoagulation tubes. Hetland et al (6) have reported that EDTA plasma VEGF levels increased by 34% and 80% respectively after 1 and 2 hours of blood storage at room temperature in healthy individuals and by 28% and 64% in rheumatoid arthritis patients. They found no differences after 2-9 freeze-thaw cycles, but an unexpected decrease of 8% after the 10 th cycle. This could be due to uncompleted freeze-thaw cycles. Indeed in our experiments, we first established the protocol for complete freeze-thawing of the samples at each we verified that β-2 microglobulin remained stable under all experimental conditions of this study, which was the case.
Baechler et al (32) have shown that gene expression profiles from fresh peripheral blood samples are significantly different from the profiles of samples shipped overnight. They observed that VEGF shows higher expression levels after overnight incubation of blood at room temperature.
Debey et al (30) have proposed that signaling events associated with hypoxia and stress responses might be induced in peripheral blood samples analysed after a delay. The same mechanism would explain the increase in tissue VEGF, observed over increasing cold ischemia delays.
Consistent with this concept, some evidences indicate that VEGF also participates in some physical responses to hypoxia and shows higher expression levels after overnight incubation of blood (32) (33) (34) . In solid tissue, the mechanism of VEGF expression variation is a direct response to hypoxia. The increase of VEGF expression is under the control of a direct effector of hypoxia, Hypoxia Inducible factor 1 (HIF1α ) whose pathway targets the expression of many other genes with local pro-angiogenic effect, such as stromal cell-derived factor alpha (SDF1α), vascular endothelial growth factor receptor 1(VEGFR1), platelet deriving growth factor-beta (PDGF-ß), fibroblast growth factor-2 (FGF-2). In addition, stabilization/degradation balance of these proteins at normoxia is changed under hypoxic conditions (35) . In our study based on immunofluorescence analysis of muscle biopsies, despite the standardisation of VEGF expression detection, the use of non-tumor tissue, we had to face intrinsic variation levels from 1 sample compared to the others. In addition, we show there is a peak effect of VEGF expression ranging between 30
and 60 min time points. This result means that it is not possible to predict the biological quality of a sample, i. Finally, our results suggest that the best conditions for measuring both circulating VEGF and its gene expression are to reduce time between blood collection and centrifugation, and to avoid multiple freeze-thaw cycles. In the present work, we could not decipher if a specific sample collection tube type was better than the others tested. Serum is the most stable, but we have to take into account that values are also due to intracellular release. The optimal conditions for measuring non-tumor tissue VEGF levels are to freeze the tissue within 15 min following excision.
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